Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
Findings support once‑daily dosing and reinforce PALI‑2108’s potential
Read the full article on the original site.
Read Full Article
Findings support once‑daily dosing and reinforce PALI‑2108’s potential
Read the full article on the original site.
Read Full Article